 |
Doug Macron is the editor of GenomeWeb's Gene Silencing News. He covers research and therapeutic applications of RNAi, miRNA, and other gene-silencing technologies. E-mail Doug Macron or follow his GenomeWeb Twitter account at @Genesilencing. |
UniQure Enters RNAi Field with Benitec Cross-Licensing Deal
December 06, 2012
UniQure Enters RNAi Field with Benitec Cross-Licensing Deal
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- UniQure, Collaborators Secure $3.2M Eurostar Grant for Huntington’s Disease Effort
May 23, 2013 / Gene Silencing News - With Allowance of US Patent Application, Veritas Aims to Outlicense RNAi Delivery Technology
April 18, 2013 / Gene Silencing News - Arrowhead HBV Drug Shows Efficacy in Chimp Model
March 14, 2013 / Gene Silencing News - Benitec Raises Funds for HCV Trial through Private Placement
March 7, 2013 / Gene Silencing News - Arrowhead Publishes Rodent, Primate Data on Preclinical Hepatitis B Therapy
February 28, 2013 / Gene Silencing News